Contact Us

News & Events

Press Releases

EPI announces collaboration with the University of Texas MD Anderson Cancer Center to evaluate Liquid Tissue-SRM tests for matching the most appropriate targeted therapies with lung cancer patients. 
Feb. 13, 2012

Dr. Jon Burrows new President and Chief Executive Officer. 
Feb. 1, 2012

Expression Pathology Obtains Second U.S. Patent. The claims of the patent cover methods that increase the range of proteins and protein modifications which can be analyzed using the company’s patented methods used in Liquid Tissue-SRM assays and the Liquid Tissue MS Protein Prep Kit.
March 24, 2011

Expression Pathology and Children's Oncology Group to Measure IGF-1R expression in Pediatric Clinical Rhabdomyosarcoma Tissue
February 1, 2011

Expression Pathology provides Roche Liquid Tissue®-SRM Protein Biomarker Assay Services in Drug Development
January 11, 2011

Thermo Fisher announced a collaboration with Expression Pathology to develop Liquid Tissue-SRM Assays of Cancer Proteins in Microdissected FFPE Tissue
December 16, 2009

Mayo Clinic Licenses Liquid Tissue® Patent for Amyloidosis Proteomic Assay
November 17, 2009


See Us At The Following Meetings

Biomarker Summit 2012
March 15-16, 2012, San Diego
"Quantitation of multiplex cancer pathway proteins in FFPE tissues using targeted mass spectrometry" by Dr. Jon Burrows, President and CEO of Expression Pathology, invited speaker.

ABRF 2012
March 17-20, Orlando
" Protein assays in FFPE tissue – From laser microdissection to multiplexed SRM mass spectrometry"
presented by Thomas G. Guiel, Chief Operating Officer, Expression Pathology. Opening presentation of the Tissue Proteomics Workshop, March 18.

AACR 2012
March 31-April 4, Chicago
Meet us at booth 1605.